Navigation Links
Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2009 Financial Results on Monday, November 10th, at 4:30 P.M. EST
Date:11/7/2008

TORONTO, Nov. 7 /PRNewswire-FirstCall/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) will hold a conference call on Monday, November 10, 2008 at 4:30 P.M. EST to discuss the First Quarter fiscal 2009 financial results. Dr. Tony Cruz, Chairman and Chief Executive Officer of the Company, will host the call. Transition will announce its financial results for this period in a press release to be issued prior to the call. In order to participate in the conference call, please call 1-800-954-1051 (North America), 1-212-231-2901 (International). A replay of the conference call will be available on Transition's website http://www.transitiontherapeutics.com for seven days following the call.

About Transition

Transition is a biopharmaceutical company, developing novel therapeutics for disease indications with large markets. Transition's lead products include ELND005 (AZD-103) for the treatment of Alzheimer's disease and TT-223 for the treatment of diabetes. Transition has an emerging pipeline of preclinical drug candidates acquired externally and developed internally using its proprietary drug discovery engine. Transition's shares are listed on the NASDAQ under the symbol "TTHI" and the Toronto Stock Exchange under the symbol "TTH". For additional information about the Company, please visit http://www.transitiontherapeutics.com.

Notice to Readers: Information contained in our press releases should be considered accurate only as of the date of the release and may be superseded by more recent information we have disclosed in later press releases, filings with the OSC, SEC or otherwise. Except for historical information, this press release may contain forward-looking statements, relating to expectations, plans or prospects for Transition, including conducting clinical trials and potential efficacy of its products. These statements are based upon the current expectations and beliefs of Transition's management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include factors beyond Transition's control and the risk factors and other cautionary statements discussed in Transition's quarterly and annual filings with the Canadian commissions.


'/>"/>
SOURCE Transition Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Schering-Plough Announces Transition of Animal Health Leadership
2. ACS Signs $27 Million Contract with Alaska to Transition Fiscal Agent Services for State Medicaid Program
3. MidSouth eHealth Alliance to Transition to Commercial Software Solution from Informatics Corporation of America
4. Transition Therapeutics Announces No Material Change
5. Transitions Optical Offers Tips on How to Protect Eyes for Outdoor Sports Fans
6. Transition Therapeutics Announces Executive Management Appointments
7. AGA Medical Announces Management Transition
8. Booth Radiology Associates Chooses IDC To Complete Its Transition To Digital Imaging
9. GCI Successfully Transitions All Traffic to Galaxy 18 Satellite
10. Get the Facts on the Albuterol Inhaler Transition
11. AUDIO from Medialink and Transitions Optical: What You Cant See May Harm You
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... ... “Life Will Never Be The Same” is a fictional tale about growing up with ... is the creation of published author, Kim T. Briggs, a self-described “big kid” who ... religion and philosophy from Judson University in Elgin, Illinois. Having written numerous Christian drama ...
(Date:12/5/2016)... ... ... has joined the Retina Group of New York (RGONY) specializing in uveitis and ... and has been providing tertiary medical and surgical retinal care on Long Island for over ... peers. Growing up in a family of doctors, Dr. Shah emulated the role of ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... excellent way to ensure moisture measurements are consistently correct. However, regular performance ... , Now, METTLER TOLEDO offers a solution: SmartCal™ . This innovative ...
(Date:12/5/2016)... OH (PRWEB) , ... December 05, 2016 , ... ... engineering solution called the CardioQuick Patch® significantly improves the reproducibility and accuracy of ... in various healthcare settings. , Over the last 60 years, studies have ...
(Date:12/4/2016)... ... December 03, 2016 , ... "Perfect Harmony comes with 20 ... FCPX editors to create professional looking video in a matter of minutes," said ... a beautifully designed 3D environment for placing in personal media. Twenty pre-made layouts ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... PharmaBoardroom today releases its new 70 page ... ... companies, investors, policymakers, and stakeholders crucial insight into Switzerland ... , home to some of the world,s most important international health institutions ... Roche, and with a number one ranking globally in terms of ease ...
(Date:12/4/2016)... SAN DIEGO , Dec. 3, 2016 Johnson ... filed on behalf of purchasers of Zimmer Biomet Holdings, Inc. ... September 7, 2016 through October 31, 2016 (the "Class Period"). ... It designs, manufactures, and markets orthopaedic reconstructive products, such as ... ...
(Date:12/4/2016)... A highly innovative, personalized cell-based treatment for a high-risk form of the ... from Children,s Hospital of Philadelphia today reported new ... (ALL). The physician-scientists presented findings at the annual meeting of ... . Continue Reading ... ...
Breaking Medicine Technology: